论文部分内容阅读
据药敏试验观察复治肺结核患者中耐多药结核病(MDR-TB)发生率,循治疗传递进程分析MDR-TB 形成原因,并对符合诊断标准的35例 MDR-TB 患者重新制定方案督导治疗,观察疗效。结果 MDR-TB发生率为57.4%,只治不管、只治不教、治不规范、治不彻底等医源性因素是 MDR-TB 形成的主要原因。治疗9月后,35例患者中,11%死亡,28.6%痰菌转阴,52%X 线病灶显吸或吸收,说明 MDR-TB 治疗困难,死亡率高,应予高度重视。提高医生专业素质、归口管理、督导化疗、强化宣教是防止发生 MDR-TB 的关键。
According to the susceptibility test, the incidence of MDR-TB in retreatment tuberculosis patients was observed. The causes of MDR-TB formation were analyzed according to the progress of treatment, and 35 cases of MDR-TB patients who met the diagnostic criteria were redesigned to supervise the treatment , Observe the effect. Results The incidence of MDR-TB was 57.4%. Only MDR-TB was the main cause of MDR-TB. After 9 months of treatment, 11% of 35 patients died, 28.6% of sputum negative and 52% of X-ray showed smoking or absorption, indicating that MDR-TB treatment is difficult and the mortality rate should be given high priority. To improve the professional quality of doctors, centralized management, supervise chemotherapy, and strengthen mission education is the key to prevent the occurrence of MDR-TB.